CARR vs NAMSW
Carrier Global Corp (CARR) versus NewAmsterdam Pharma Company N.V. Warrant (NAMSW) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) common stock listed on NASDAQ.
Latest reported CARR revenue for 2025-12-31 was $21.75B. Net income was $1.48B. Revenue was up 322.4% from 2024-12-31 to 2025-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
NAMSW does not have a complete income-statement cache yet.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. NAMSW currently screens at market cap $0.
Not investment advice. Open the CARR and NAMSW stock pages for the full models.
Not investment advice.